Is PTEN loss associated with clinical outcome measures in human prostate cancer?

Inactivating PTEN mutations are commonly found in prostate cancer, resulting in an increased activation of Akt. In this study, we investigate the role of PTEN deletion and protein expression in the development of hormone-refractory prostate cancer using matched hormone-sensitive and hormone-refracto...

Descripción completa

Detalles Bibliográficos
Autores principales: McCall, P, Witton, C J, Grimsley, S, Nielsen, K V, Edwards, J
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2008
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2570524/
https://www.ncbi.nlm.nih.gov/pubmed/18854827
http://dx.doi.org/10.1038/sj.bjc.6604680

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2570524/
https://www.ncbi.nlm.nih.gov/pubmed/18854827
http://dx.doi.org/10.1038/sj.bjc.6604680

Ejemplares similares